Ceftazidime

头孢他啶

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCeftazidime
Drug Alias NameCeftazidima头孢他定头孢噻甲羧肟Ceftazidimum凯复定 +[20] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[13] 
Global Approved IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsGenital Diseases, Female +[11] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1983/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesSandozTeligentHikma Pharmaceuticals +[4] 
Inactive CompaniesGlaxosmithkline PlcPharmaceutical Associates IncB Braun Medical
Active IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Inactive IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[10] 

Other Information

ATC CodeJ01DD02
Related LinksWikipediaDrugBankKEGG